首页 | 本学科首页   官方微博 | 高级检索  
     


Gonadal-sparing total body irradiation with the use of helical tomotherapy for nonmalignant indications
Authors:Khaled Dibs,Austin J. Sim,Jos   A. Pe  agaricano,Kujtim Latifi,Genevieve A. Garcia,Julia A. Peters,Michael L. Nieder,Sungjune Kim,Timothy J. Robinson
Affiliation:1.Department of Radiation Oncology, The Ohio State University, Columbus OH, United States; 2.Department of Radiation Oncology, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, United States; 3.Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States; 4.Department of Biostatistics and Bioinformatics, H. Lee Moffit Cancer Center and Research Institute, Tampa, FL, United States
Abstract:BackgroundThe aim was to demonstrate the feasibility and technique of gonadal sparing total body irradiation (TBI) with helical tomotherapy. Total body irradiation is a common part of the conditioning regimen prior to allogeneic stem cell transplantation. Shielding or dose-reduction to the gonads is often desired to preserve fertility, particularly in young patients undergoing transplant for non-malignant indications. Helical tomotherapy (HT) has been shown to be superior to traditional TBI delivery for organ at risk (OA R) doses and dose homogeneity.Materials and methodsWe present two representative cases (one male and one female) to illustrate the feasibility of this technique, each of whom received 3Gy in a single fraction prior to allogeneic stem cell transplant for benign indications. The planning target volume (PTV) included the whole body with a subtraction of OA Rs including the lungs, heart, and brain (each contracted by 1cm) as well as the gonads (testicles expanded by 5 cm and ovaries expanded by 0.5 cm).ResultsFor the male patient we achieved a homogeneity index of 1.35 with a maximum and median planned dose to the testes of 0.53 Gy and 0.35 Gy, respectively. In-vivo dosimetry demonstrated an actual received dose of 0.48 Gy. For the female patient we achieved a homogeneity index of 1.13 with a maximum and median planned dose to the ovaries of 1.66 Gy and 0.86 Gy, respectively.ConclusionGonadal sparing TBI is feasible and deliverable using HT in patients with non-malignant diseases requiring TBI as part of a pre-stem cell transplant conditioning regimen.
Keywords:gonadal sparing   helical tomotherapy   marrow transplantation
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号